在病理性血管生成中N6 - - 甲基氨酸的修饰
Bin Li1, Hanqin Xuan2, Yuye Yin3
1Institute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China.
Life sciences
|January 20, 2024
概括
N6-甲基氨酸 (m6A) RNA修饰是血管发育和癌症和缺血病等疾病的关键. 了解m6A机制可以改善抗血管性疗法,以更好地治疗疾病.
科学领域:
- 血管生物学和医学 血管生物学和医学
- 表观遗传学和RNA生物学
背景情况:
- 血管系统对于生理过程至关重要,但异常的血管形成是癌症和缺血症等疾病的基础.
- 抗血管生成策略是治疗性的,但需要更深入的机制理解,以提高有效性.
- 越来越多地认识到N6-甲基氨酸 (m6A) RNA修饰在调节血管发育中的作用.
研究的目的:
- 审查m6A在各种血管相关疾病中的调节作用.
- 阐明m6A甲基化调节剂在病理过程中影响血管生成的机制.
- 突出针对m6A在血管疾病中的治疗潜力.
主要方法:
- 关于m6A和血管疾病的临床前和临床研究的文献综述.
- 对将m6A调节器与血管生成联系起来的分子机制的分析.
- 综合当前关于m6A在癌症,眼睛,神经和缺血性疾病中的作用的知识.
主要成果:
- m6A修饰是血管发育和血管生成的关键调节者.
- m6A通路的失调有助于主要血管相关疾病的发病.
- 特定的m6A调节器影响病态血管生成,提供治疗点.
结论:
- m6ARNA甲基化是血管恒温和疾病的重要因素.
- 准m6A通路为开发新型抗血管生成疗法提供了一个有希望的策略.
- 对m6A机制的进一步研究将促进血管病理的治疗.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis
5.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Notch Signaling Pathway
4.3K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


